Positive immunological data in HCC
Immunicum announces phase I/II data showing tumor specific immune responses that directly correlate with prolonged survival rates for the majority of INTUVAX-treated HCC patients.
Read the press release here: Press release 160418 – HCC positive immunological data
Notice: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4805